News
News

The latest updates from AFAR.

Grantees in the News: Research co-authored by 4 AFAR grantees on cellular senescence and age-related blood clots in Cell Reports

Sep 30
2019

Grantees in the News: Research co-authored by 4 AFAR grantees on cellular senescence and age-related blood clots in Cell Reports

On September 24, 2019, Cell Reports published new research by AFAR experts Natan Basisty, PhD, Judith Campisi, PhD, Pankaj Kapahi, PhD, and Christopher D. Wiley, PhD, that links cellular senescence to age-related blood clots. Dr. Basisty is a 2015 Diana Jacobs Kalman/AFAR Scholarships for Research in the Biology of Aging recipient, and a Postdoctoral Research Fellow at the Schilling Lab at the Buck Institute. Dr. Campisi is a 1990 AFAR Research Grant recipient, and a 2002 Irving S. Wright Award recipient. She is also the head of the Campisi Lab at the Buck Institute. Dr. Kapahi is a 2006 Glenn Foundation for Medical Research Breakthroughs…


View MoreREAD MORE


Grantee in the News: William Mair on “Five Myths About Aging” in The Washington Post

Sep 27
2019

Grantee in the News: William Mair on “Five Myths About Aging” in The Washington Post

On September 20, 2019, The Washington Post featured science-backed insights from AFAR expert William Mair, PhD. In the feature article, which has since been widely picked up by other media nationwide, Dr. Mair which address myths about aging, healthspan, and longevity. Dr. Mair is a 2010 Ellison/AFAR Senior Postdoctoral Fellowship Award recipient and a 2017 Glenn Foundation for Medical Research Breakthroughs in Gerontology (BIG) Award recipient. He is also an Associate Professor of Genetics and Complex Diseases at the Harvard T.H. Chan School of Public Health. Read the article, “Five myths about aging,” here.


View MoreREAD MORE


Board Member in the News: David Sinclair’s New Book “Lifespan: Why We Age – and Why We Don’t Have To” published by Atria Books

Sep 27
2019

Board Member in the News: David Sinclair’s New Book “Lifespan: Why We Age – and Why We Don’t Have To” published by Atria Books

AFAR congratulates Board Member David Sinclair, PhD, AO, on the release of his book,  Lifespan: Why We Age – and Why We Don’t Have To,  published by Atria Books, a subsidiary of Simon & Schuster. In this groundbreaking book, Dr. Sinclair reveals a bold new theory for why we age. “David is a pioneer poised to change how we think about and understand aging,” AFAR Executive Director Stephanie Lederman endorses on the book’s back cover. Dr. Sinclair is a 2000 AFAR Research Grant recipient. He is also a Professor in the Department of…


View MoreREAD MORE


AFAR in the News: AFAR whitepaper by S. Jay Olshansky on healthspan of 2020 candidates in JAMA Network

Sep 21
2019

AFAR in the News: AFAR whitepaper by S. Jay Olshansky on healthspan of 2020 candidates in JAMA Network

  On September 11, 2019, JAMA Network spotlighted the recent research-backed whitepaper by AFAR expert S. Jay Olshansky, PhD,  arguing how healthspan matters more than age when considering a presidential candidate. Referencing the AFAR-published whitepaper, Longevity and Health of US Presidential Candidates for the 2020 Election, the article reinforces the whitepaper’s emphasis on healthspan, not chronological age.  “Given the candidates’ favorable health and longevity forecasts,” the article states, “‘there is reason to question whether age should be used at all in making judgments about prospective presidential candidates.’” Dr. Olshansky is on AFAR…


View MoreREAD MORE


Ask the Expert Interview: Nathan LeBrasseur on Sarcopenia, the protein Myostatin, and Exercise on Next Avenue

Sep 19
2019

Ask the Expert Interview: Nathan LeBrasseur on Sarcopenia, the protein Myostatin, and Exercise on Next Avenue

AFAR is excited to announce the latest addition to our “Ask the Expert” interview series. In this exclusive interview, AFAR expert Nathan LeBrasseur, PT, PhD lends his insights on sarcopenia, his research on the protein myostatin, and the benefits of exercise to prevent loss of muscle mass. Dr. LeBrasseur is a 2002 Glenn/AFAR Scholarship for Research in the Biology of Aging recipient, and a 2019 Vincent Cristofalo Rising Star Award in Aging Research recipient.  He is also a Consultant, Professor, and Co-Chair of Research in the Department of Physical Medicine and Rehabilitation at the Mayo Clinic. Read…


View MoreREAD MORE


Grantee in the News: Brian Kennedy on the health care crisis in Forbes

Sep 06
2019

Grantee in the News: Brian Kennedy on the health care crisis in Forbes

On August 30, 2019 Forbes featured insights from AFAR expert Brian Kennedy, PhD, on the challenge of an aging society. Dr. Kennedy positioned the health care needs of our aging population as the “climate change of healthcare,” as many of the solutions rest on changing peoples’ behavior by modifying diet and other lifestyle habits. Dr. Kennedy is a 2003 AFAR Research Grant recipient, and a 2008 Medical Student Training in Aging Research (MSTAR) program awardee. He is also a Professor at the Buck Institute for Research on Aging. Read the article, “Falling Life Expectancy Becoming The ‘Climate Change’…


View MoreREAD MORE


Board Member in the News: Nir Barzilai on TAME Trials & Metformin’s clinical impact in Healio’s Endocrine Today

Sep 06
2019

Board Member in the News: Nir Barzilai on TAME Trials & Metformin’s clinical impact in Healio’s Endocrine Today

On August 30, 2019  Healio’s Endocrine Today featured the insights of AFAR expert Nir Barzilai, MD, on the goals and benefits of the upcoming TAME trials, which will evaluate metformin’s clinical impact. Dr. Barzilai is AFAR’s Deputy Scientific Director, a 1994 AFAR Research Grant recipient, a 1997 Paul B. Beeson Emerging Leaders Career Development Award in Aging scholar, a 2010 Irving S. Wright Award winner, the  Director at the Institute for Aging Research and distinguished Professor at the Albert Einstein College of Medicine. Read the article, “Metformin may hold anti-aging promise to increase ‘health span…


View MoreREAD MORE


Board Member in the News: Jay Olshansky on healthspan and longevity of 2020 candidates in ABC News, AP, NY Times, and more.

Sep 04
2019

Board Member in the News: Jay Olshansky on healthspan and longevity of 2020 candidates in ABC News, AP, NY Times, and more.

On August 31, 2019 , the Associated Press featured insights from S. Jay Olshansky, PhD, in an article on the longevity and healthspan of the 2020 election candidates. The article cites his 2011 research , “Aging of US Presidents,” which  found that 23 of 34 presidents who had died of natural causes lived beyond the average life expectancy of men the same age when they were inaugurated. The AP feature has been picked up considerably nationwide, including such high profile outlets as ABC News and The New York Times. The article is inspired by Dr. Olshansky’s recent AFAR-published whitepaper, “Longevity and Health…


View MoreREAD MORE


Board Member in the News: Nir Barzilai on the TAME Trials in Medium

Sep 19
2019

Board Member in the News: Nir Barzilai on the TAME Trials in Medium

On September 5, 2019, Medium elemental featured insights from AFAR expert Nir Barzilai, MD, on the potential of the AFAR-managed TAME Trials to transform healthspan through drugs like metformin to treat aging. “Based on what scientists have already observed with diabetic and prediabetic patients taking metformin,” the article states, “Barzilai is confident the drug has a beneficial effect on the biological mechanisms underlying aging.” On the TAME trials, the article says, “TAME mainly seeks to answer the question of whether metformin will help lengthen life and stave off disease.” Dr. Barzilai is AFAR’s…


View MoreREAD MORE


Board Member in the News: Nir Barzilai on TAME Trials & Metformin’s clinical impact in Healio’s Endocrine Today

Sep 06
2019

Board Member in the News: Nir Barzilai on TAME Trials & Metformin’s clinical impact in Healio’s Endocrine Today

On August 30, 2019  Healio’s Endocrine Today featured the insights of AFAR expert Nir Barzilai, MD, on the goals and benefits of the upcoming TAME trials, which will evaluate metformin’s clinical impact. Dr. Barzilai is AFAR’s Deputy Scientific Director, a 1994 AFAR Research Grant recipient, a 1997 Paul B. Beeson Emerging Leaders Career Development Award in Aging scholar, a 2010 Irving S. Wright Award winner, the  Director at the Institute for Aging Research and distinguished Professor at the Albert Einstein College of Medicine. Read the article, “Metformin may hold anti-aging promise to increase ‘health span…


View MoreREAD MORE




BACK TO TOPBACK TO TOP